Skip to main content
. Author manuscript; available in PMC: 2016 Nov 14.
Published in final edited form as: Mucosal Immunol. 2015 Dec 9;9(5):1278–1287. doi: 10.1038/mi.2015.129

Table 1.

Mouse lung lipid mediators (pg/lung)

Q1 Q3 0 hrs
SEM
24 hrs
SEM
72 hrs
SEM
RvD1 375 141 0.4 ± 0.1 1.6 ± 0.4 5.1 ± 1.6
RvD2 375 175 0.8 ± 0.3 10.7 ± 3.7 36.4 ± 12
RvD3 375 147 0.2 ± 0.1 1.2 ± 0.5 2.7 ± 1
RvD5 359 199 16.2 ± 7.8 14.8 ± 6.8 35.2 ± 4.5
RvD6 359 159 2.4 ± 0.3 2.7 ± 0.4 6.8 ± 1.1
AT-RvD1 375 141 0.6 ± 0.2 3.3 ± 1.1 6.7 ± 1.4
AT-RvD3 375 147 * * * * * *
PD1 359 153 0.7 ± 0.1 2.5 ± 0.7 3.8 ± 0.8
10S,17S-diHDHA 359 153 41.7 ± 23.6 209.9 ± 119.2 394.1 ± 58.5
AT-PD1 359 153 0.8 ± 0.2 4.2 ± 1 8.7 ± 4.5
MaR1 359 177 0.7 ± 0.3 * ± * * ± *
RvE1 349 161 * ± * * ± * * ± *
RvE2 333 253 4.5 ± 0.6 4.9 ± 1.6 42.7 ± 20.1
RvE3 333 201 5.4 ± 1.3 66 ± 22 199.3 ± 48.2
LxA4 351 115 4.5 ± 1.9 49.2 ± 24 102.4 ± 54.1
LxB4 351 221 123.5 ± 0.6 696.6 ± 1.6 1094 ± 20.1
*

= below limit (0.1pg)